2020
DOI: 10.1111/cod.13589
|View full text |Cite
|
Sign up to set email alerts
|

Maculopapular rash to S‐carboxymethylcysteine‐lysine (carbocisteine)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…However, it may rarely induce cutaneous adverse reactions such as maculopapular rash and fixed drug eruption (FDE). 4,5 To our knowledge, this is the first case report of SJS after carbocisteine ingestion confirmed by oral re-administration. Recently, in a disproportionality analysis on drug-induced SJS from the World Health Organization pharmacovigilance database, carbocisteine had a strong signal as a causative drug, in spite of no relevant cases reported on PubMed to date.…”
mentioning
confidence: 72%
“…However, it may rarely induce cutaneous adverse reactions such as maculopapular rash and fixed drug eruption (FDE). 4,5 To our knowledge, this is the first case report of SJS after carbocisteine ingestion confirmed by oral re-administration. Recently, in a disproportionality analysis on drug-induced SJS from the World Health Organization pharmacovigilance database, carbocisteine had a strong signal as a causative drug, in spite of no relevant cases reported on PubMed to date.…”
mentioning
confidence: 72%